.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Chinese Patent Office
McKesson
AstraZeneca
Queensland Health
Boehringer Ingelheim
US Army
Federal Trade Commission
Teva
Dow

Generated: June 26, 2017

DrugPatentWatch Database Preview

EMLA Drug Profile

« Back to Dashboard

Which patents cover Emla, and when can generic versions of Emla launch?

Emla is a drug marketed by Actavis Labs Ut Inc and Astrazeneca and is included in two NDAs.

The generic ingredient in EMLA is lidocaine; prilocaine. There are twenty-nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the lidocaine; prilocaine profile page.

Summary for Tradename: EMLA

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list13
Clinical Trials: see list50
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EMLA at DailyMed

Pharmacology for Tradename: EMLA

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 1992ABRXYesYes► Subscribe► Subscribe
Astrazeneca
EMLA
lidocaine; prilocaine
DISC;TOPICAL020962-001Feb 4, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: EMLA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 19924,529,601► Subscribe
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 19924,562,060► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Chinese Patent Office
Teva
Argus Health
AstraZeneca
Julphar
Queensland Health
Chubb
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot